← Back to Clinical Trials
Recruiting NCT07381166

NCT07381166 The Effect of İnhaler Training and Reminders on Medication on Adherence in Elderly Individuals

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07381166
Status Recruiting
Phase
Sponsor Çanakkale Onsekiz Mart University
Condition Elderly (People Aged 65 or More)
Study Type INTERVENTIONAL
Enrollment 64 participants
Start Date 2026-01-21
Primary Completion 2026-05-23

Eligibility & Interventions

Sex All sexes
Min Age 65 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Metered Dose Inhaler TrainingMetered Dose Inhaler Reminder CardMetered Dose Inhaler Application Video

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 64 participants in total. It began in 2026-01-21 with a primary completion date of 2026-05-23.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study will evaluate the effect of metered-dose inhaler training and reminders on treatment adherence in elderly individuals.

Eligibility Criteria

Inclusion criteria for the study: * Age ≥ 65 years old * Having at least basic literacy, * Receiving metered-dose inhaler therapy for at least 6 months, * Being hospitalized in the pulmonary ward, * Presenting to the pulmonary function test unit, * Presenting to the pulmonary outpatient clinic, * Signing the informed consent form for participation in the study, * Having internet access and a mobile device with Android/iOS operating system, * Being able to use a telephone, * Having no communication barriers, * Being able to use the inhaler without needing assistance, * Making an error in at least one of the usage steps according to the MDI usage skills chart. Exclusion criteria for the study: * Age \<65 * Illiteracy * Receiving metered-dose inhaler therapy for \<6 months * Outpatient treatment * Being hospitalized in the intensive care unit * Being hospitalized in wards other than the pulmonary ward (such as surgery, physical therapy) * Visiting outpatient clinics other than the pulmonary clinic (such as surgery, physical therapy) * Not signing the informed consent form for participation in the study * Not having internet access and a mobile device with Android/iOS operating system * Not having telephone skills * Having communication barriers * Requiring assistance while using the inhaler * Not making any errors in the usage steps according to the MDI usage skills chart * Wanting to withdraw from the study/withdrawing from participation during the research process * Not completing the questionnaire

Contact & Investigator

Central Contact

Sevda Ates Associate Professor

✉ sevdaefil@comu.edu.tr

📞 +902862181397

Principal Investigator

Sevda Ateş, Associate Professor

PRINCIPAL INVESTIGATOR

Çanakkale Onsekiz Mart University

Frequently Asked Questions

Who can join the NCT07381166 clinical trial?

This trial is open to participants of all sexes, aged 65 Years or older, studying Elderly (People Aged 65 or More). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07381166 currently recruiting?

Yes, NCT07381166 is actively recruiting participants. Contact the research team at sevdaefil@comu.edu.tr for enrollment information.

Where is the NCT07381166 trial being conducted?

This trial is being conducted at Çanakkale, Turkey (Türkiye).

Who is sponsoring the NCT07381166 clinical trial?

NCT07381166 is sponsored by Çanakkale Onsekiz Mart University. The principal investigator is Sevda Ateş, Associate Professor at Çanakkale Onsekiz Mart University. The trial plans to enroll 64 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology